30Jul
Increased regulatory scrutiny of foreign direct investments in the healthcare sector
Key Takeaways - - Foreign Direct Investment (FDI) controls are proliferating around the globe. Since the pandemic, “health” has become a particular focus. - Several countries have adapted their existing FDI rules, or introduced new ones, to address concerns about national autonomy and supply chain disruption. Some of these changes are general, but some are specific to healthcare. - Plans for cross-border M&A in the healthcare sector should take close account of potential FDI screening...
By:
Dechert LLP
Related
Although there have only been a handful of confirmed cases of the 2019 Novel Coronavirus (2019-nCoV ...
Read More >
In today’s edition of Daily Compliance News: Trump wants cut of Microsoft TikTok deal. (WaPo) BP r...
Read More >
The New York State Legislature passed several bills at the end of its 2019 session which, yet again,...
Read More >
In Seyfarth’s fourth installment in its 2019 Trade Secrets Webinar Series, Seyfarth attorneys Krist...
Read More >
Recently, the U.S. Equal Employment Opportunity Commission (“EEOC”) weighed in and provided guidan...
Read More >
On October 7, 2019, the U.S. Department of Labor announced a proposed rule that would allow employer...
Read More >